These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4800573)

  • 1. [Circulating anticoagulants in hemophilia A].
    Michalski R; Lopaciuk S
    Acta Haematol Pol; 1973; 4(3):203-9. PubMed ID: 4800573
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic safety of recombinant factor VIII. The rFactor VIII Clinical Trial Group.
    Abildgaard CF
    Semin Hematol; 1991 Apr; 28(2 Suppl 1):44. PubMed ID: 1908127
    [No Abstract]   [Full Text] [Related]  

  • 3. Acquired circulating anticoagulants in hemophilia A.
    Strauss HS
    N Engl J Med; 1969 Oct; 281(16):866-73. PubMed ID: 5812255
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
    Sawecka J; Skulimowska J; Windyga J; Lopaciuk S; Kościelak J
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):352-6. PubMed ID: 16088320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transfusion problems in immunocoagulopathies].
    Lechner K; Stych H
    Bibl Haematol; 1971; 37():199-205. PubMed ID: 5138905
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating anticoagulant in patients with hemophilia A.
    Uszyński L; Lopaciuk S
    Pol Med J; 1969; 8(4):862-9. PubMed ID: 4105591
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoreactive factor VIII in carriers of hemophilia A+ and A-.
    Lechner K
    Thromb Diath Haemorrh; 1973 May; 29(2):240-6. PubMed ID: 4762253
    [No Abstract]   [Full Text] [Related]  

  • 8. [Circulating anticoagulants in hemophilia].
    Josso F; Cosson A; Gazengel C; Allain JP
    Rev Fr Transfus; 1972 Sep; 15(3):281-98. PubMed ID: 4657669
    [No Abstract]   [Full Text] [Related]  

  • 9. [Circulating anticoagulant in hemophilia A: laboratory evidence of a coagulation factor 8 inhibitor].
    Hule V
    Vnitr Lek; 1967 Sep; 13(9):859-65. PubMed ID: 6081657
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of carriers of haemophilia.
    Ekert H; Helliger H; Muntz RH
    Thromb Diath Haemorrh; 1973 Nov; 30(2):255-62. PubMed ID: 4589771
    [No Abstract]   [Full Text] [Related]  

  • 11. [Circulating anticoagulants against coagulation factors with special reference to anti-factor VIII:C].
    Aznar JA
    Sangre (Barc); 1985; 30(4-C):813-8. PubMed ID: 3937252
    [No Abstract]   [Full Text] [Related]  

  • 12. [Incidence of inhibitors in children with hemophilia A].
    Izquierdo-Ramírez J; Contreras-Mulato EL; Sotelo-Ham EI; Marín-Palomares T; Dueñas-González MT; Benítez-Aranda H
    Bol Med Hosp Infant Mex; 1988 Sep; 45(9):578-82. PubMed ID: 3142496
    [No Abstract]   [Full Text] [Related]  

  • 13. Factor VIII inhibitors: structure and function in autoantibody and hemophilia A patients.
    Hoyer LW; Scandella D
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):1-5. PubMed ID: 7524160
    [No Abstract]   [Full Text] [Related]  

  • 14. Tolerance to factor VIII inhibitors in hemophilia A patients: a French twist.
    Pascual V; Capra JD
    J Clin Invest; 1996 Mar; 97(6):1357-8. PubMed ID: 8617864
    [No Abstract]   [Full Text] [Related]  

  • 15. [Poly-electrolyte fractionated porcine factor VIII in the treatment of hemophilia A].
    Ferencz T; Skopál J; Csáki C; Laczkó M; Schuler D; Borsi J
    Orv Hetil; 1993 Dec; 134(52):2873-5. PubMed ID: 8272354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Circulating anticoagulants].
    Krulik M; Debray J; Vergoz D; Yvart J
    Sem Hop; 1971 Jun; 47(28):1820-7. PubMed ID: 4327218
    [No Abstract]   [Full Text] [Related]  

  • 17. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
    Torghabeh HM; Pourfathollah A; Shooshtari MM; Yazdi ZR
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of anti-human and anti-porcine factor VIII antibody titers in patients with hemophilia].
    Windyga J; Rzymkiewicz L; Lopaciuk S
    Acta Haematol Pol; 1996; 27(1):27-31. PubMed ID: 8629440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus anticoagulants and their relationship with the inhibitors against coagulation factor VIII: considerations on the differentiation between the 2 circulating anticoagulants.
    Tripodi A; Mancuso ME; Chantarangkul V; Clerici M; Bader R; Meroni PL; Santagostino E; Mannucci PM
    Clin Chem; 2005 Oct; 51(10):1883-5. PubMed ID: 16099933
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of factor VIII antibody by combined factor VIII and cyclophosphamide.
    Nilsson IM; Hedner U; Holmberg L
    Acta Med Scand; 1974; 195(1-2):64-72. PubMed ID: 4817094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.